部份中文异克舒令处方资料（仅供参考）
英文名：ISOXSUPRINE HCL
商品名：ISOXSUPRINE
中文名：异克舒令片
生产商：ECI PHARMACEUTICALS LLC
适应症
根据美国国家科学院-国家研究委员会对该药物的评论和/或其他信息，FDA已将药物分类如下：
可能有效：
1.用于缓解与脑血管功能不全相关的症状
2.周围血管疾病的动脉硬化闭塞症，血栓性闭塞性脉管炎（Buerger's disease）和雷诺氏病。
对效果不佳的最终分类需要进一步调查
剂量和给药
口服：每日三至四次10至20毫克
禁忌症和注意事项
口服
当以推荐剂量给药时，没有已知的口服使用禁忌症。 不应在产后或动脉出血时立即给予。
不良反应
在极少数情况下，口服药物与低血压，心动过速，胸痛，恶心，呕吐，头晕，腹部窘迫和严重皮疹的发生有关。 如果出现皮疹，应停药。
尽管可获得的证据表明这些反应与异丙肾上腺素的时间关联，但偶然的关系既不能被证实也不会被驳斥。
β-肾上腺素能受体兴奋剂如盐酸异丙肾上腺素已被用于抑制早产。 在这种使用下可能发生母体和胎儿心动过速。 据报道，母亲接受异丙肾上腺素的婴儿出现低钙血症，低血糖，低血压和肠梗阻。 据报道，用β-兴奋剂治疗的母亲患有肺水肿。 异丙肾上腺素盐酸盐片，USP既未被批准也未推荐用于治疗早产。
包装
ISOXSUPRINE 10MG TAB 100 ISOXSUPRINE HCL ECI PHARMACEUTICALS LLC 51293060601
ISOXSUPRIN DS PWD 25GM ISOXSUPRINE HCL MEDISCA INC/DS 38779023404 
ISOXSUPRINE HYDROCHLORIDE USP 100GM DS ISOXSUPRINE HCL MEDISCA INC/DS 38779023405
ISOXSUPRINE HYDROCHLORIDE USP 1000GM DS ISOXSUPRINE HCL MEDISCA INC/DS 38779023409
------------------------------------------------
SPL UNCLASSIFIED SECTION
Rx Only
DESCRIPTION
Each tablet taken orally contains Isoxsuprine Hydrochloride, USP with the following chemical structure:
C18H23NO3 • HCl
p-Hydroxy-α[1-[(methyl-2-phenoxy-ethyl)amino]ethyl]benzyl alcohol hydrochloride.
Quantitative Ingredient InformationEach tablet taken orally contains 10 or 20 mg Isoxsuprine HCl
Pharmacological ClassPeripheral Vasodilator
INDICATIONS
Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:
Possibly Effective1.For the relief of symptoms associated with cerebrovascular insufficiency.
2.In peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (Buerger's disease) and Raynaud's disease.
Final classification of the less-than-effective indications requires further investigation.
CONTRAINDICATIONS
There are no known contraindications to oral use when administered in recommended doses.
Isoxsuprine Hydrochloride, USP should not be given immediately postpartum or in the presence of arterial bleeding.
PRECAUTIONS
Pediatric UseSafety and effectiveness in pediatric patients have not been established.
ADVERSE REACTIONS
On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.
Although available evidence suggests a temporal association of these reactions with Isoxsuprine Hydrochloride, a causal relationship can be neither confirmed nor refuted.
Beta Adrenergic receptor stimulants such as Isoxsuprine Hydrocholoride have been used to inhibit pre-term labor.
Maternal and fetal tachycardia may occur under such use. Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received Isoxsuprine Hydrochloride. Pulmonary edema has been reported in mothers treated with beta stimulants. Isoxsuprine Hydrochloride is neither approved nor recommended for use in the treatment of premature labor.
DOSAGE AND ADMINISTRATION
Oral: 10 to 20 mg, three or four times daily.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6582e24-9414-43b8-ac6f-b1422e3197cf